ONPATTRO® (patisiran) is an infusion medication designed to treat adults with hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). It decreases symptoms of constipation, diarrhea, dizziness, vomiting, and difficulty urinating, as well as improving the patient’s gait and reducing anxiety and depression.
Please refer to the full prescribing information.
Note: Please speak with your healthcare provider for more information if you think this therapy might be right for you.
How do I make a referral or transition my treatment to Infusion Associates?
3. One of our intake specialists will contact your healthcare provider to confirm receipt of your referral.
4. We will then verify benefits, obtain any required prior authorizations, and contact you to schedule an appointment.